Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vivienne A Ezzat"'
Autor:
Holly L. Daw, Ciaran Goswell, Charles Butcher, Jeremy Kalindjian, Bruna C. Di Nubila, Vinit Sawhney, Martin Lowe, Filip R. Zemrak, Vivienne A. Ezzat
Publikováno v:
Heart Rhythm. 20:S602-S603
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39904d9e38547d37abd62d9b2d50405c
https://doi.org/10.1016/j.hrthm.2023.03.1273
https://doi.org/10.1016/j.hrthm.2023.03.1273
Autor:
Nicholas Crust, Natasha Bloodworth, Holly Daw, Amy L. Wharmby, Sarah Whittaker-Axon, Sandra Ladkin, Katherine VonKlemperer, Filip Zemrak, Vivienne A. Ezzat, Archana Rao, Martin Lowe, Reza Ashrafi, Vinit Sawhney
Publikováno v:
Heart Rhythm. 20:S601-S602
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b795a7e63cfbc7701595bed956f58fcc
https://doi.org/10.1016/j.hrthm.2023.03.1271
https://doi.org/10.1016/j.hrthm.2023.03.1271
Autor:
Mark T. Kearney, Karen E. Porter, Richard M Cubbon, Nadira Yuldasheva, Amir Aziz, Hema Viswambharan, Jaswinder K. Sethi, Edward R. Duncan, Shouhong Xuan, Afroze Abbas, Matthew Kahn, Antonio Vidal-Puig, Peter J. Grant, Adil Rajwani, Vivienne A. Ezzat, Helen Imrie, Piruthivi Sukumar, Jessica Smith, Matthew C. Gage, Stephen B. Wheatcroft, Ajay M. Shah
Publikováno v:
Diabetes
Low concentrations of insulin-like growth factor (IGF) binding protein-1 (IGFBP1) are associated with insulin resistance, diabetes, and cardiovascular disease. We investigated whether increasing IGFBP1 levels can prevent the development of these diso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614c1ece0bfa30d7469c141d5a9963a2
https://doi.org/10.2337/db11-0963
https://doi.org/10.2337/db11-0963
Autor:
Helen Imrie, Edward R. Duncan, Adil Rajwani, Stephen B. Wheatcroft, Ramzi A. Ajjan, Afroze Abbas, Richard M Cubbon, Vivienne A. Ezzat, Peter J. Grant, Matthew Kahn, Mark T. Kearney, Matthew C. Gage, Hema Viswambharan
Publikováno v:
Endocrinology. 150:4575-4582
Obesity and type 2 diabetes mellitus are characterized by insulin resistance, reduced bioavailability of the antiatherosclerotic signaling molecule nitric oxide (NO), and accelerated atherosclerosis. IGF-I, the principal growth-stimulating peptide, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9955f742ac837e2e9f1ae00d26b42fdb
https://doi.org/10.1210/en.2008-1641
https://doi.org/10.1210/en.2008-1641
Publikováno v:
Nature Clinical Practice Cardiovascular Medicine. 5:289-293
Premature ventricular complexes are a common form of arrhythmia and are typically considered to be benign. In this month's Case Study, however, Ezzat and colleagues present a patient with dilated cardiomyopathy which was postulated to be caused by pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dad84e4cd417639402a2a2453450f205
https://doi.org/10.1038/ncpcardio1180
https://doi.org/10.1038/ncpcardio1180
Publikováno v:
Diabetes, Obesity and Metabolism. 10:198-211
Patients with insulin resistance and type 2 diabetes have an excessive risk of cardiovascular disease (CVD); this increased risk is not fully explained by traditional risk factors such as hypertension and dyslipidaemias. There is now compelling evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a80eb1a47cec402efe4b0d79505a7b
https://doi.org/10.1111/j.1463-1326.2007.00709.x
https://doi.org/10.1111/j.1463-1326.2007.00709.x
Autor:
Vivienne A. Ezzat, Mark T. Kearney, Ajay M. Shah, Edward R. Duncan, Stephen B. Wheatcroft, Simon Walker, Jian-Mei Li
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 293:E1311-E1319
Insulin resistance is well established as an independent risk factor for the development of type 2 diabetes and cardiovascular atherosclerosis. Most studies have examined atherogenesis in models of severe insulin resistance or diabetes. However, by t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c760dd16cc89b713bcc4477c4321a01
https://doi.org/10.1152/ajpendo.00299.2007
https://doi.org/10.1152/ajpendo.00299.2007
Publikováno v:
Current Diabetes Reviews. 2:51-60
A number of population studies have suggested that hyperinsulinaemia is an independent risk factor for the development of cardiovascular atherosclerosis. Furthermore, there is an emerging body of evidence supporting a role for insulin as both a vasor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7513ac5ec75fef4a02e7922abb7aada
https://doi.org/10.2174/157339906775473590
https://doi.org/10.2174/157339906775473590
Autor:
Stephen B. Wheatcroft, Simon M. Walker, Mark Kearney, P A Crossey, Narayana Anilkumar, Edward R. Duncan, Ajay M. Shah, Lucilla Poston, Vivienne A. Ezzat, Gillian Douglas
Publikováno v:
Diabetes
OBJECTIVE—Insulin resistance is an independent risk factor for the development of cardiovascular atherosclerosis. A key step in the development of atherosclerosis is endothelial dysfunction, manifest by a reduction in bioactivity of nitric oxide (N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccbd37bf6c87414db128f73476788c3d
https://pubmed.ncbi.nlm.nih.gov/18835939
https://pubmed.ncbi.nlm.nih.gov/18835939
Autor:
Mark T. Kearney, Stephen C. R. Williams, Gema Medina-Gomez, P A Crossey, William P. Cawthorn, Jaswinder K. Sethi, John R. Miell, Vivienne A. Ezzat, Stephen B. Wheatcroft, Ajay M. Shah, Michael Modo, Antonio Vidal-Puig
Proliferation of adipocyte precursors and their differentiation into mature adipocytes contributes to the development of obesity in mammals. IGF-I is a potent mitogen and important stimulus for adipocyte differentiation. The biological actions of IGF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620ca33eaac0495ca854dd541a90fdbe
https://europepmc.org/articles/PMC4295171/
https://europepmc.org/articles/PMC4295171/
